Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|September 13, 2019
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatmentMichael Fehlings, Suchit Jhunjhunwala, Marcin Kowanetz, et al.
Current Opinion in Chemical Biology|January 18, 2006
Molecular and functional analysis using live cell microarraysDaniel S Chen, Mark M Davis
Springer Seminars in Immunopathology|April 19, 2005
Cellular immunotherapy: antigen recognition is just the beginningDaniel S Chen, Mark M Davis
Nature|November 28, 2014
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patientsRoy S Herbst, Jean-Charles Soria, Marcin Kowanetz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2017
Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural MesotheliomaNamrata S Patil, Luisella Righi, Hartmut Koeppen, et al.
Cell|March 9, 2019
VEGF in Signaling and Disease: Beyond Discovery and DevelopmentRajendra S Apte, Daniel S Chen, Napoleone Ferrara
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia StudyDavid F McDermott, Jeffrey A Sosman, Mario Sznol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2012
Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1Daniel S Chen, Bryan A Irving, F Stephen Hodi
Cancer Chemotherapy and Pharmacology|June 16, 2018
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumorsColin D Weekes, Lee S Rosen, Anna Capasso, et al.
Plos One|June 8, 2018
Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancerMonika A Jarzabek, William R Proctor, Jennifer Vogt, et al.
Pageof 8